Partners4Access

Maastricht, London, Zurich - Partners4Access (P4A), a global leader in pharmaceutical innovation and orphan drug access, is proud to share the results of its latest staff survey, reflecting a workplace culture rooted in collaboration, inclusivity, and...

Partners4Access, a global leader in pharmaceutical innovation and orphan drug access are proud to announce that Consultant, Olivia Johns has accepted the role of DMD Strategy Advisor.

Partners4Access (P4A), a global leader in market access for orphan drugs and advanced therapies, is excited to host the P4A Access Summit 2025: JCA & Market Expansion Unlocked in Zug, Switzerland, on Tuesday, 13th May 2025.

Partners4Access, a global leader in pharmaceutical innovation and orphan drug access are proud to announce that Pina (Josephina) Haberl has accepted the role of Chief People Officer.

P4A will present three thought provoking posters at ISPOR Europe 2024 in Barcelona. With these posters, P4A showcases its commitment to advancing health economics and outcomes research (HEOR) in orphan drugs and ATMPs.

RarePULSE® Achieves Registered Trademark for Omnichannel Service We are thrilled to announce that RarePULSE® our innovative omnichannel service has officially received registered trademark status from the Intellectual Property Office (IPO).

Partners4Access (P4A), a leading global consultancy specializing in market access for orphan drugs, gene therapies, and rare disease treatments, is excited to announce that three of its poster abstracts have been accepted for presentation

Partners4Access (P4A), a leading global consultancy specializing in orphan drugs, cell and gene therapies, market access, is proud to announce its membership with Health Technology Assessment international (HTAi).

London, United Kingdom, April 29, 2022- Leading specialist market access consultancy Partners4Access analyst's have been awarded 'Highly Commended'' Analyst Team of the Year 2022 by BHBIA BOBI Awards and have been shortlisted to the last four teams as...

Leading specialist market access consultancy Partners4Access (P4A) is to host a free webinar to share insights on key emerging trend in launch strategy for new drugs within EU-5 for pharma/biotech manufacturers.